This program has been developed with the collaboration and generous support of Boston Medical Center.
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring material CME activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
CNE Contact Hours: 0.25
In order to receive credit, participants must view the content, and complete the post-test and evaluation. Participants who receive a grade of 70% or greater on the post-test will receive credit.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for opioid education.
Physicians, nurse practitioners, registered nurses, nurses, physician assistants, dentists, and pharmacists
At the conclusion of this activity, participants will be better able to:
Date of Original Release: February 6, 2017
Date of Expiration: February 5, 2020
Estimated time to complete: 15 minutes
The US, and Massachusetts, in particular are confronting an opioid morbidity and mortality crisis. In response to this crisis the Massachusetts legislature has passed opioid prescribing laws and the Massachusetts Medical Society and Centers for Disease Control and Prevention have developed opioid prescribing guidelines. Among Massachusetts clinicians there is confusion about which opioid prescribing practices are now mandated by law and which are recommended by state and national guidelines. Therefore there is a need to educate clinicians, in a clinically useful way, about the current laws and guidelines to allow for the medically appropriate and safe us or opioid for the treatment of pain.
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices occurs.
Daniel P. Alford, MD, MPH (CME Course Director)
Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Donna Beers, BSN, RN-BC, CARN (CNE Course Advisor)
Manager, Primary Care Clinical Transformation
Boston Medical Center
Faculty members listed above have no relevant relationships with commercial interests to disclose. Faculty members listed above do not plan on discussing off-label/investigational uses of commercial products.
Patti-Ann Collins, DNP, MSN/MBA, RN, Lead Nurse Planner, BUSM; Ilana Hardesty, Program Operations Manager, BUSM
Planning committee members have nothing to disclose with regard to commercial support.
Reviewers have nothing to disclose with regard to commercial support.
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
© 2019 Trustees of Boston University. Site by Signal.